|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
AstraZeneca |
|---|---|
| Information provided by: | AstraZeneca |
| ClinicalTrials.gov Identifier: | NCT00658255 |
Purpose
The purpose of this study is to compare the therapeutic effects of formoterol in Symbicort with formoterol in Oxis Turbuhaler for the treatment of adults with stable asthma.
| Condition | Intervention | Phase |
|---|---|---|
|
Stable Asthma |
Drug: budesonide/formoterol Drug: formoterol |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Open Label, Crossover Assignment, Safety Study |
| Official Title: | A Randomized, Multicenter, Open-Label, Active-Controlled, Single-Dose, 5-Period, Incomplete Block, Cross-Over Study to Evaluate the Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort pMDI or Oxis Turbuhaler to Adults With Stable Asthma |
| Estimated Enrollment: | 175 |
| Study Start Date: | October 2002 |
| Study Completion Date: | May 2003 |
| Arms | Assigned Interventions |
|---|---|
| 1: Experimental | Drug: budesonide/formoterol |
| 2: Active Comparator | Drug: formoterol |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Study ID Numbers: | SD-039-0729, D5896C00729 |
| Study First Received: | April 1, 2008 |
| Last Updated: | March 27, 2009 |
| ClinicalTrials.gov Identifier: | NCT00658255 History of Changes |
| Health Authority: | United States: Food and Drug Administration |
|
stable asthma adults formoterol |
Symbicort Oxis Turbuhaler bronchodilation |
|
Neurotransmitter Agents Bronchial Diseases Symbicort Adrenergic Agents Adrenergic beta-Agonists Budesonide Anti-Asthmatic Agents Asthma Adrenergic Agonists |
Lung Diseases, Obstructive Hypersensitivity Respiratory Tract Diseases Lung Diseases Hypersensitivity, Immediate Formoterol Peripheral Nervous System Agents Bronchodilator Agents Respiratory Hypersensitivity |
|
Respiratory System Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Bronchial Diseases Immune System Diseases Symbicort Adrenergic beta-Agonists Physiological Effects of Drugs Anti-Asthmatic Agents Asthma Pharmacologic Actions |
Adrenergic Agonists Lung Diseases, Obstructive Hypersensitivity Respiratory Tract Diseases Autonomic Agents Therapeutic Uses Lung Diseases Hypersensitivity, Immediate Formoterol Peripheral Nervous System Agents Bronchodilator Agents Respiratory Hypersensitivity |